Dec 13, 2021
By: Rounak JainThe company’s shares will debut on the stock exchanges today after its IPO was subscribed 219 times. Its issue price is ₹453 per share.
Credit: Tega-Industries
Approved its second interim dividend for FY 2021-22 at ₹13.5 per share, with the record date being December 18.
Credit: Vedanta
The return of the controversial Boeing 737 Max aircraft has run into another issue after SpiceJet’s Mumbai-Kolkata flight experienced a mid-air emergency and had to turn back.
Credit: BCCL
Its board will meet on December 15 to consider options for raising funds via a further issue of securities either through public or private offerings.
Credit: Unsplash
The Hyderabad-based pharma company received approval for an abbreviated new drug application (ANDA) VeraRing from the US drug regulator.
Credit: Dr-Reddys-Laboratories
US pharma giant Gilead has sued Aurobindo from launching copies of Letairis, a drug used in the treatment of pulmonary hypertension.
Credit: Aurobindo-Pharma
Bagged a tentative approval from the US drug regulator for Cariprazine capsules, a generic drug used in the treatment of schizophrenia.
Credit: Cadila-Healthcare
To expand its two-wheeler alloy wheel capacity by 20 lakh units per annum at its Maharashtra plant. Its subsidiary to enhance four-wheeler alloy wheel capacity by 3.6 lakh units per annum at its Gujarat plant.
Credit: Minda-Industries
Its board will meet on December 15 to consider a proposal for an interim dividend.
Credit: BCCL
It will consider a proposal for a stock split that would split each existing equity share into five. Its shares were trading at ₹1,682 on December 10.
Credit: Greenlam-Industries